Richard J Daly Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

CPRX Quotes by TradingView

Richard J Daly is President and CEO of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 234,824 shares of CPRX, which is worth approximately $4.96 Million. The most recent transaction as insider was on Jun 04, 2024, when has been sold 17,323 shares (Common Stock, par value $0.001 per share) at a price of $15.97 per share, resulting in proceeds of $276,648. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 235K
0% 3M change
58.66% 12M change
Total Value Held $4.96 Million

Richard J Daly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2024
SELL
Open market or private sale
$276,648 $15.97 p/Share
17,323 Reduced 6.87%
234,824 Common Stock, par valu...
Jun 04 2024
BUY
Exercise of conversion of derivative security
$160,400 $4.01 p/Share
40,000 Added 13.69%
252,147 Common Stock, par valu...
Feb 15 2024
SELL
Payment of exercise price or tax liability
-
1,186 Reduced 0.56%
212,147 Common Stock, par valu...
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
4,000 Added 1.84%
213,333 Common Stock, par valu...
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
1,333 Added 0.63%
209,333 Common Stock, par valu...
Dec 07 2023
BUY
Exercise of conversion of derivative security
$67,800 $1.13 p/Share
60,000 Added 22.39%
208,000 Common Stock, par valu...
May 12 2023
BUY
Exercise of conversion of derivative security
$39,500 $0.79 p/Share
50,000 Added 25.25%
148,000 Common Stock, par valu...
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
4,000 Added 3.92%
98,000 Common Stock, par valu...
Dec 06 2022
BUY
Exercise of conversion of derivative security
-
1,334 Added 1.4%
94,000 Common Stock, par valu...
Aug 24 2022
BUY
Exercise of conversion of derivative security
$101,200 $2.53 p/Share
40,000 Added 30.15%
92,666 Common Stock, par valu...
Jan 25 2022
BUY
Exercise of conversion of derivative security
$167,500 $3.35 p/Share
50,000 Added 48.7%
52,666 Common Stock, par valu...
Dec 03 2021
BUY
Exercise of conversion of derivative security
-
1,333 Added 33.33%
2,666 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
1,333 Added 50.0%
1,333 Common Stock, par valu...

Also insider at

OPNT
OPIANT PHARMACEUTICALS, INC. Healthcare
Director
RJD

Richard J Daly

President and CEO
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CPRX